Pharmacological interventions for smoking cessation: an overview and network meta‐analysis

K Cahill, S Stevens, R Perera… - Cochrane database of …, 2013 - cochranelibrary.com
Background Smoking is the leading preventable cause of illness and premature death
worldwide. Some medications have been proven to help people to quit, with three licensed …

Psychosocial interventions for supporting women to stop smoking in pregnancy

C Chamberlain, A O'Mara‐Eves… - Cochrane database …, 2017 - cochranelibrary.com
Background Tobacco smoking remains one of the few preventable factors associated with
complications in pregnancy, and has serious long‐term implications for women and babies …

Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary

CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …

Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease

KM Kew, A Seniukovich - Cochrane Database of Systematic …, 2014 - cochranelibrary.com
Background Inhaled corticosteroids (ICS) are anti‐inflammatory drugs that have proven
benefits for people with worsening symptoms of chronic obstructive pulmonary disease …

Prevention of acute exacerbations of COPD: American college of chest physicians and Canadian thoracic society guideline

GJ Criner, J Bourbeau, RL Diekemper, DR Ouellette… - Chest, 2015 - Elsevier
BACKGROUND: COPD is a major cause of morbidity and mortality in the United States as
well as throughout the rest of the world. An exacerbation of COPD (periodic escalations of …

Smoking cessation for people with chronic obstructive pulmonary disease

EAM van Eerd, RM van der Meer… - Cochrane Database …, 2016 - cochranelibrary.com
Background Smoking cessation is the most important treatment for smokers with chronic
obstructive pulmonary disease (COPD), but little is known about the effectiveness of different …

Electronic nicotine delivery systems and/or electronic non-nicotine delivery systems for tobacco smoking cessation or reduction: a systematic review and meta …

R El Dib, EA Suzumura, EA Akl, H Gomaa, A Agarwal… - BMJ open, 2017 - bmjopen.bmj.com
Objective A systematic review and meta-analysis to investigate the impact of electronic
nicotine delivery systems (ENDS) and/or electronic non-nicotine delivery systems (ENNDS) …

Smoking and Chronic Obstructive Pulmonary Disease (COPD). Parallel Epidemics of the 21st Century

R Laniado-Laborín - International journal of environmental research and …, 2009 - mdpi.com
One hundred million deaths were caused by tobacco in the 20th century, and it is estimated
that there will be up to one billion deaths attributed to tobacco use in the 21st century …

Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments

L Zuo, F He, GG Sergakis… - … of Physiology-Lung …, 2014 - journals.physiology.org
Cigarette smoking (CS) can impact the immune system and induce pulmonary disorders
such as chronic obstructive pulmonary disease (COPD), which is currently the fourth leading …

Tiotropium versus placebo for chronic obstructive pulmonary disease

C Karner, J Chong, P Poole - Cochrane database of …, 2014 - cochranelibrary.com
Background Tiotropium is an anticholinergic agent which has gained widespread
acceptance as a once daily maintenance therapy for symptoms and exacerbations of stable …